Stanley-Laman Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $355K | Sell |
|
|||||
|
2024
Q4 | $529K | Sell |
|
|||||
|
2024
Q3 | $1.47M | Sell |
|
|||||
|
2024
Q2 | $1.47M | Buy |
|
|||||
|
2024
Q1 | $1.4M | Sell |
|
|||||
|
2023
Q4 | $1.6M | Buy |
|
|||||
|
2023
Q3 | $361K | Hold |
|
|||||
|
2023
Q2 | $399K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $3.2M | Sell |
|
|||||
|
2020
Q3 | $3.04M | Buy |
|
|||||
|
2020
Q2 | $2.61M | Buy |
|
|||||
|
2020
Q1 | $2.49M | Buy |
|
|||||
|
2019
Q4 | $2.95M | Sell |
|
|||||
|
2019
Q3 | $2.84M | Sell |
|
|||||
|
2019
Q2 | $3.55M | Sell |
|
|||||
|
2019
Q1 | $3.48M | Sell |
|
|||||
|
2018
Q4 | $3.59M | Sell |
|
|||||
|
2018
Q3 | $3.96M | Sell |
|
|||||
|
2018
Q2 | $3.3M | Sell |
|
|||||
|
2018
Q1 | $3.41M | Sell |
|
|||||
|
2017
Q4 | $3.59M | Sell |
|
|||||
|
2017
Q3 | $3.54M | Sell |
|
|||||
|
2017
Q2 | $3.84M | Buy |
|
|||||
|
2017
Q1 | $825K | Sell |
|
|||||
|
2016
Q4 | $1.61M | Buy |
|
|||||
|
2016
Q3 | $1.61M | Sell |
|
|||||
|
2016
Q2 | $2.04M | Sell |
|
|||||
|
2016
Q1 | $2.2M | Sell |
|
|||||
|
2015
Q4 | $2.64M | Sell |
|
|||||
|
2015
Q3 | $2.7M | Buy |
|
|||||
|
2015
Q2 | $2.66M | Buy |
|
|||||
|
2015
Q1 | $2.7M | Sell |
|
|||||
|
2014
Q4 | $2.44M | Buy |
|
|||||
|
2014
Q3 | $1.96M | Buy |
|
|||||
|
2014
Q2 | $1.9M | Buy |
|
|||||
|
2014
Q1 | $1.91M | Buy |
|